TR200605624A2 - Pharmaceutical dosage form - Google Patents

Pharmaceutical dosage form

Info

Publication number
TR200605624A2
TR200605624A2 TR2006/05624A TR200605624A TR200605624A2 TR 200605624 A2 TR200605624 A2 TR 200605624A2 TR 2006/05624 A TR2006/05624 A TR 2006/05624A TR 200605624 A TR200605624 A TR 200605624A TR 200605624 A2 TR200605624 A2 TR 200605624A2
Authority
TR
Turkey
Prior art keywords
dosage form
core tablet
pharmaceutical dosage
enteric coating
pantoprazole
Prior art date
Application number
TR2006/05624A
Other languages
Turkish (tr)
Inventor
Uslu Abdullah
Original Assignee
Nobel İlaç Sanayi̇ Ve Ti̇caret Aş.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nobel İlaç Sanayi̇ Ve Ti̇caret Aş. filed Critical Nobel İlaç Sanayi̇ Ve Ti̇caret Aş.
Priority to TR2006/05624A priority Critical patent/TR200605624A2/en
Priority to EP07852324A priority patent/EP2086517A2/en
Priority to PCT/TR2007/000121 priority patent/WO2008045009A2/en
Publication of TR200605624A2 publication Critical patent/TR200605624A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Pantoprazol etkin maddesini içeren buluş konusu farmasötik katı dozaj şekli bir çekirdek tableti, bir enterik kaplamayı ve çekirdek tablet ile enterik kaplama arasında bulunan bir ön kaplamayı içermektedir. Çekirdek tablet, pantoprazol etkin maddesi dışında bağlayıcı olarak sodyum karboksimetilselüloz ve dolgu maddesi olarak isomalt içermektedir.The pharmaceutical solid dosage form of the present invention containing the pantoprazole active ingredient comprises a core tablet, an enteric coating and a precoat between the core tablet and the enteric coating. The core tablet contains sodium carboxymethylcellulose as a binder and isomalt as a filler besides the pantoprazole active substance.

TR2006/05624A 2006-10-10 2006-10-10 Pharmaceutical dosage form TR200605624A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
TR2006/05624A TR200605624A2 (en) 2006-10-10 2006-10-10 Pharmaceutical dosage form
EP07852324A EP2086517A2 (en) 2006-10-10 2007-10-10 Pharmaceutical dosage form
PCT/TR2007/000121 WO2008045009A2 (en) 2006-10-10 2007-10-10 Pharmaceutical dosage form

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2006/05624A TR200605624A2 (en) 2006-10-10 2006-10-10 Pharmaceutical dosage form

Publications (1)

Publication Number Publication Date
TR200605624A2 true TR200605624A2 (en) 2008-05-21

Family

ID=39283297

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2006/05624A TR200605624A2 (en) 2006-10-10 2006-10-10 Pharmaceutical dosage form

Country Status (3)

Country Link
EP (1) EP2086517A2 (en)
TR (1) TR200605624A2 (en)
WO (1) WO2008045009A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105380919A (en) * 2015-11-20 2016-03-09 世贸天阶制药（江苏）有限责任公司 Pantoprazole sodium enteric-coated tablet and preparation method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9402431D0 (en) * 1994-07-08 1994-07-08 Astra Ab New tablet formulation
DE19752843C2 (en) * 1997-11-28 2003-01-09 Byk Gulden Lomberg Chem Fab Pharmaceutical preparation in tablet or pellet form for pantoprazole and omeprazole
GB0003782D0 (en) * 2000-02-17 2000-04-05 Dumex Ltd As Process

Also Published As

Publication number Publication date
WO2008045009A2 (en) 2008-04-17
WO2008045009A3 (en) 2008-12-31
EP2086517A2 (en) 2009-08-12

Similar Documents

Publication Publication Date Title
DK3103448T3 (en) Pharmaceutical compositions comprising an S1P modulator
EA201290984A1 (en) PHARMACEUTICAL PHARMACEUTICAL COMPOSITIONS, PREVENTING ABUSE
HK1132175A1 (en) Combination of a cholinesterase inhibitor and a compound with 5-ht6 receptor affinity
BR112012024139A2 (en) double-layer pharmaceutical formulations containing opioid agonists and antagonists.
CR20110110A (en) PHARMACEUTICAL COMPOSITION
CL2009000903A1 (en) Pharmaceutical compositions comprising a core containing a weakly basic drug selected from butyrophenone derivatives, an alkaline pH buffer layer and a controlled release coating, a method for preparing said compositions and pharmaceutical dosage forms that include them.
WO2009117130A3 (en) Extended release forumulation containing a wax
IL197933A (en) Kinase inhibitors, pharmaceutical compositions comprising such compounds and uses thereof
SI2395002T1 (en) Pharmaceutical composition containing a heterocyclic modulator of atp-binding cassette transporters.
FR2949062B1 (en) NEW PHARMACEUTICAL FORMULATIONS AGAINST MEASURING MEDICINES
EP2078731A4 (en) Pharmaceutical composition comprising anti-hb-egf antibody as active ingredient
EA201201202A1 (en) ORAL PHARMACEUTICAL COMPOSITION CONTAINING DABIGATRANE EXTILE
MX2009002903A (en) Combination of nmda- receptor ligand and a compound with 5-ht6 receptor affinity.
MX2016007134A (en) Improved pharmaceutical compositions of pimobendan.
MX354416B (en) Nalbuphine-based formulations and uses thereof.
TR200604349A2 (en) Pharmaceutical compositions containing aripiprazole
EA201190125A1 (en) TABLETS FOR COMBINED THERAPY
TW200806282A (en) Solid dosage formulations
WO2008129517A3 (en) A stabilized delayed release pharmaceutical composition of rabeprazole
WO2007090661A3 (en) Active substance combination comprising azolylcarbinol compounds
AU2012347200A8 (en) Tablet capable of combatting misuse by injection
EA201101596A1 (en) COMPOSITION FOR CONTINUOUS DELIVERY OF MEDICINE CONTAINING CONTAINING GEOPOLYMERIC CONNECTING
CL2013001979A1 (en) Pharmaceutical tablet composition, comprising immunosuppressive compounds, modulators of the s1p receptor, which also includes a desiccant and is coated with a moisture barrier.
UY31452A1 (en) IMPROVED TABLET COATING
PH12014501408A1 (en) Immediate release multi unit pellet system